国家癌症数据库中机器人辅助肺叶切除术的结果分析
该研究利用美国国家癌症数据库(NCDB)分析2010至2014年465家医院的7645例机器人辅助肺叶切除术。倾向匹配分析显示,经验丰富与经验不足医院在30天和90天死亡率上无显著差异。中转开胸是30天和90天死亡率的预测因素,且在经验更丰富的医院中转开胸患者的90天死亡率更高。
要点
- 机器人肺叶切除术总中转开胸率为9.2%。
- 经验丰富与不足医院死亡率无显著差异。
- 中转开胸显著增加30天和90天死亡风险。
核心结论
- 经验丰富医院与经验不足医院的机器人肺叶切除术死亡率无显著差异。
- 中转开胸是30天和90天死亡率的预测因素,且在经验更丰富的医院中转开胸患者死亡率更高。
研究设计与样本
- 回顾性队列研究,使用美国国家癌症数据库(NCDB)分析2010至2014年465家医院的7645例机器人肺叶切除术。
- 医院按开始报告机器人肺叶切除术的年份分类,主要结局为围手术期并发症、死亡率和中转开胸率。
主要发现
- 总体中转开胸率为9.2%(n=702)。
- 倾向匹配分析显示,经验丰富与经验不足医院30天死亡率(1.07% vs 2.03%,p=0.092)和90天死亡率(2.35% vs 3.63%,p=0.104)无显著差异。
- 中转开胸预测30天死亡率(OR 2.54,CI 1.56-4.14)和90天死亡率(OR 2.68,CI 1.83-3.91)。
- 中转开胸患者90天死亡率更高,见于经验年数2年(p=0.043)、3年(p=0.002)和4年(p=0.003)。
临床怎么用
- 机器人肺叶切除术中应重视中转开胸的风险,并优化患者选择以降低中转率。
- 经验积累可能降低中转率,但中转开胸患者的死亡风险仍需警惕。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Robotic-assisted thoracoscopic surgery (RobATS) lobectomy is becoming more common for the treatment of lung cancer. As with any relatively new technology, there is the assumption that greater experience leads to greater proficiency. The objective of this study was to analyze outcomes of patients undergoing RobATS lobectomy as hospitals gain experience, and to describe outcomes after conversion to open procedures. STUDY DESIGN: The National Cancer Database (NCDB) was used to analyze robotic lobectomies for lung cancer from 2010 to 2014. Individual hospitals were categorized by the year they began reporting robotic lobectomies to the NCDB. Primary outcomes were perioperative morbidity and mortality and rate of conversion to open lobectomy. RESULTS: There were 7,645 robotic lobectomies identified from 465 hospitals. The overall conversion rate was 9.2% (n = 702). A propensity-matched analysis showed no significant difference between experienced and inexperienced hospitals with respect to 30-day mortality (1.07% vs 2.03%, p = 0.092) or 90-day mortality (2.35% vs 3.63%, p = 0.104). Conversion to open was a predictor of 30-day mortality (odds ratio [OR] 2.54, CI 1.56 to 4.14) and 90-day mortality (OR 2.68, CI 1.83 to 3.91). Patients who underwent conversion had higher 90-day mortality compared with patients not undergoing conversion, in years of experience: 2 (p = 0.043), 3 (p = 0.002), and 4 (p = 0.003). CONCLUSIONS: Mortality after RobATS lobectomy at experienced hospitals is not significantly different than at inexperienced hospitals. Though conversion rates decrease with experience, patients who undergo conversion have higher mortality than those who do not, particularly in hospitals with more experience. This suggests that a deliberate effort to increase experience with and improve patient selection for RobATS lobectomies may ameliorate the conversions and their attendant sequelae.
引用
- Arnold BN, Thomas DC, Narayan R, et al. Robotic-Assisted Lobectomies in the National Cancer Database. J Am Coll Surg. 2018. PMID: 29574177. doi:10.1016/j.jamcollsurg.2018.03.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。